missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Lorvotuzumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Marque: Invitrogen MA541708
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Lorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.Spécification
Lorvotuzumab | |
Recombinant Monoclonal | |
Unconjugated | |
BB-10901; huN901-DM1; IMGN901 | |
Human NCAM1/CD56 | |
100 μg | |
Primary | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid | |
Chemical |
ELISA, SDS-Page | |
2.55 mg/mL | |
PBS with no preservative; pH 7.5 | |
Human | |
Protein A | |
RUO | |
Chemical | |
Antibody | |
IgG1 κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu